Additionally, the question remains about the long-term effects of modulator therapy in the responsive population and how CFTR regulation by cellular components and the complex cell-to-cell and cell-to-microenvironment interactions become different in the context of modulators and redefine the disease course of CF. This evidence concerns the gene CFTR and cystic fibrosis.